Defense Advanced Research Projects AgencyTagged Content List

Harness Biological Systems

Leveraging genetic technologies to engineer synthetic or natural organisms

Showing 51 results for Bio-systems RSS
Dr. Eric Lander is president and founding director of the Broad Institute of MIT and Harvard. A geneticist, molecular biologist, and mathematician, he has played a pioneering role in the reading, understanding, and biomedical application of the human genome. He was a principal leader of the Human Genome Project. With his colleagues, Dr. Lander has developed and applied powerful methods for discovering the molecular basis of rare genetic diseases, common diseases, and cancer.
Dr. Justin Gallivan has been a Program Manager in the Biological Technologies Office since 2014. He is interested in many facets of synthetic biology, including engineering microbial communities to produce small molecules or to prevent disease, reprogramming multicellular organisms to perform complex tasks, and creating living materials capable of self-repair.
Dr. Justin Sanchez was named Director of BTO in May 2016, after serving as Acting Deputy Director of BTO since December 2015. The mission of BTO is to develop breakthrough technologies and capabilities for national security. He oversees 10 program managers working in areas of science and technology development including neurotechnology, gene editing, synthetic biology, and outpacing infectious diseases.
Dr. Lori Adornato, a Program Manager in the Biological Technologies Office at DARPA, focuses on the interpretation of organismal behavior and development of bio-inspired materials, as well as platforms and systems for marine sensing applications.
Dr. Nahid Bhadelia, MD, MA is an infectious diseases physician, Assistant Professor at the Boston University School of Medicine and the Medical Director of Special Pathogens Unit (SPU) at Boston Medical Center. Her specialization is in infection control issues related to emerging pathogens and highly communicable infectious diseases. She serves as the Director of Medical Response for maximum containment research at BU’s National Emerging Infectious Diseases Laboratories (NEIDL), one of two academic biosafety level 4 laboratories in the U.S.